Beyond the Birthrate: The Societal Costs of Maternal Mortality
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:
- The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study
- The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make
- Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health
- How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges
- and more!
Recent Videos
Related Content
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025Podcast
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
